February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being generated and clinical trial data released. Here is a look at last month's Top 10.

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being generated and clinical trial data released. Here is a look at last month's Top 10.

1. Patients with Multiple Artery Blockages Undergoing Coronary Artery Bypass Surgery Fare Better, Live Longer than Those Who Opt for Stenting

March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today announced publication of the DREAM-HF Phase 3 trial results in the premier peer-reviewed journal for cardiovascular medicine, the Journal of the American College of Cardiology (JACC).

February 28, 2023 — Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease, today announced the launch of the SENSORA Cardiac Disease Detection Platform.

34th Annual Cardiovascular Interventions

February 27, 2023 — Amarin Corporation plc announced that data evaluating the role of VASCEPA /VAZKEPA (icosapent ethyl) and eicosapentaenoic acid (EPA) in reducing cardiovascular events in at-risk patients will be presented at the joint ACC.23 together with the

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now